Six teams have been selected as the inaugural recipients of Additional Ventures’ Device Innovation Award, a milestone-driven program designed to accelerate the development of purpose-built medical devices for people living with single ventricle heart disease. Collectively, these awards represent up to $9M in support over the next three years.